Details of the Drug Reposition

General Information of This Drug (ID: DMAQW9M)

Drug Name	SFX-01 DMAQW9M

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Breast cancer	DIS7DPX1	2C60-2C65	Phase 2	[1]
Subarachnoid hemorrhage	DISI7I8Y	8B01	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02970682) SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer (STEM). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT02614742) SFX-01 After Subarachnoid Haemorrhage (SAS). U.S. National Institutes of Health.